Restructuring plans in pharmaceutical firms hit snag

Published: 2011-12-05 06:59:00

Updated: 2011-12-05 06:59:00

Influenced by the government’s large drug price cuts, many pharmaceutical companies are trying to survive through a massive reconstructing plan, but they are facing a strong resistance from sales persons.

A report released by the Korea Pharmaceutical Manufacturers Association forecast that som...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK